Aug 28
|
GSK shares rise on Delaware Supreme Court appeal in Zantac case
|
Jul 24
|
GSK (GSK) Earnings Expected to Grow: Should You Buy?
|
Jun 16
|
The heartburn drug giving British pharma giant GSK a $3bn headache
|
Jun 16
|
The $3bn crisis casting a shadow over Dame Emma Walmsley’s GSK
|
May 15
|
GSK PLC's Dividend Analysis
|
May 11
|
GSK plc (LON:GSK) Stock Goes Ex-Dividend In Just Four Days
|
Apr 7
|
10 Best Weight Loss Drug Stocks to Buy Now
|
Mar 28
|
GSK PLC Sponsored ADR (GSK) is Attracting Investor Attention: Here is What You Should Know
|
Mar 28
|
UPDATE 1-U.S. FDA approves Akebia's anemia drug
|
Jan 9
|
Stocks to Watch Tuesday: Boeing, Match, HPE, JetBlue
|
Jan 9
|
Health Care Roundup: Market Talk
|
Jan 9
|
FTSE 100 LIVE: Hays shares slide after 'difficult December', GSK in $1bn respiratory drug deal
|
Jan 9
|
GSK to buy asthma treatment firm Aiolos Bio in £1.1bn deal
|
Jan 9
|
GSK strikes £1.1bn deal for asthma drugmaker
|
Jan 9
|
GSK Enters Agreement to Acquire Aiolos Bio
|
Jan 9
|
Trending tickers: Apple | Samsung | GSK | Jupiter
|
Jan 9
|
GSK Expands Respiratory Pipeline With Aiolos Bio Buy
|
Dec 24
|
15 Undervalued Defensive Stocks For 2024
|
Dec 22
|
GSK to cut US prices for Advair, Valtrex and Lamictal
|
Dec 21
|
Sunak hosts bosses for Business Council gathering
|